Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 5,000 shares at $38.33 ($192K) on 2025-09-08, disclosed to the SEC on 2025-09-10.
Scheduled sale ($192k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RAPP | SELL | 2026-03-09 | $58K | — | Filing → |
| RAPP | SELL | 2025-12-01 | $151K | — | Filing → |